PNT — POINT BIOPHARMA GLOBAL INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
HoldingsHub 追踪了 PNT(POINT BIOPHARMA GLOBAL INC)近五年的季度 13F 申报数据。历史上有 132 家基金申报过持仓,其最近一期申报市值合计 $364.08M。最新季度无机构披露持仓,通常意味着该股已退出追踪基金的组合,而非不可投资。
POINT BIOPHARMA GLOBAL INC(PNT)的主要机构持有人包括 BVF INC/IL、Vanguard Group、STATE STREET CORP,按 13F 申报市值在本页 132 家持有人中排名居前。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q4 2023 | 2 | 518.83K | $6.48M | — |
| Q3 2023 | 126 | 51.78M | $342.33M | -19.5% |
| Q2 2023 | 30 | 16.46M | $148.73M | -2.0% |
| Q1 2023 | 30 | 16.64M | $118.52M | +5.9% |
| Q4 2022 | 28 | 15.44M | $108.08M | +3.3% |
| Q3 2022 | 26 | 16.34M | $126.30M | +30.3% |
| Q2 2022 | 21 | 11.09M | $75.53M | +56.5% |
| Q1 2022 | 20 | 8.22M | $65.53M | +20.0% |
表内 8 个季度中,机构持股合计减少 94%(Q1 2022 → Q4 2023);单季变动最大的是 Q2 2022(+56.5%)。
前 25 大机构持仓人(Q4 2023) — 2 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 518.70K | $6.48M | 0.15% | 新进 | |
| 127 | $1.00K | 0.00% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q3 2023 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 10.56M | $70.46M | 1.90% | 新进 | |
| 4.67M | $31.13M | 0.00% | 增持 | |
| 3.53M | $23.53M | 0.00% | 新进 | |
| 2.91M | $19.41M | 3.75% | 新进 | |
| 2.78M | $18.55M | 0.72% | 新进 | |
| 2.35M | $15.68M | 0.25% | 新进 | |
| 1.90M | $12.68M | 0.00% | 增持 | |
| 1.61M | $10.76M | 0.55% | 新进 | |
| 1.11M | $7.38M | 0.02% | 新进 | |
| 1.01M | $6.73M | 0.00% | 新进 | |
| 1.00M | $6.67M | 2.46% | 新进 | |
| 952.64K | $6.35M | 1.36% | 新进 | |
| 822.03K | $5.48M | 0.00% | 增持 | |
| 794.61K | $5.30M | 0.00% | 新进 | |
| 789.10K | $5.26M | 0.03% | 减持 | |
| 772.90K | $5.16M | 0.40% | 新进 | |
| 732.94K | $4.89M | 0.79% | 新进 | |
| 689.18K | $4.60M | 0.00% | 新进 | |
| 689.18K | $4.60M | 0.00% | 增持 | |
| 607.05K | $4.05M | 0.00% | 减持 | |
| 552.75K | $3.69M | 0.01% | 新进 | |
| 552.75K | $3.69M | 0.01% | 持有 | |
| 547.43K | $3.65M | 0.01% | 新进 | |
| 524.08K | $3.50M | 0.04% | 新进 | |
| 522.97K | $3.49M | 0.00% | 增持 |
Q2 2023 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.46M | $40.37M | 0.00% | 增持 | |
| 2.46M | $22.28M | 0.01% | 减持 | |
| 1.93M | $17.48M | 0.10% | 减持 | |
| 1.73M | $15.63M | 0.00% | 增持 | |
| 959.46K | $8.69M | 0.00% | 减持 | |
| 801.19K | $7.26M | 0.00% | 增持 | |
| 649.99K | $5.89M | 0.00% | 增持 | |
| 552.66K | $5.01M | 0.01% | 增持 | |
| 464.63K | $4.21M | 0.01% | 增持 | |
| 329.01K | $2.98M | 0.00% | 增持 | |
| 291.72K | $2.64M | 0.00% | 增持 | |
| 243.16K | $2.20M | 0.00% | 新进 | |
| 242.27K | $2.19M | 0.00% | 增持 | |
| 203.71K | $1.85M | 0.00% | 增持 | |
| 190.97K | $1.73M | 0.00% | 减持 | |
| 157.62K | $1.43M | 0.00% | 减持 | |
| 138.17K | $1.25M | 0.00% | 新进 | |
| 100.97K | $914.76K | 0.00% | 减持 | |
| 81.86K | $741.67K | 0.00% | 减持 | |
| 74.36K | $673.68K | 0.00% | 增持 | |
| 63.18K | $572.38K | 0.00% | 增持 | |
| 62.78K | $568.79K | 0.00% | 增持 | |
| 62.20K | $563.50K | 0.00% | 新进 | |
| 56.98K | $516.21K | 0.00% | 增持 | |
| 40.15K | $363.77K | 0.00% | 减持 |
Q1 2023 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.43M | $32.19M | 0.00% | 增持 | |
| 3.19M | $23.22M | 0.01% | 减持 | |
| 3.11M | $22.64M | 0.12% | 减持 | |
| 1.58M | $11.50M | 0.00% | 增持 | |
| 1.01M | $7.34M | 0.00% | 增持 | |
| 756.26K | $5.50M | 0.00% | 增持 | |
| 389.26K | $2.83M | 0.00% | 减持 | |
| 291.70K | $2.12M | 0.00% | 增持 | |
| 275.26K | $2.00M | 0.00% | 新进 | |
| 248.74K | $1.81M | 0.00% | 减持 | |
| 232.07K | $1.69M | 0.00% | 增持 | |
| 159.96K | $1.16M | 0.00% | 增持 | |
| 153.62K | $1.12M | 0.00% | 增持 | |
| 137.28K | $998.02K | 0.00% | 增持 | |
| 62.12K | $451.63K | 0.00% | 增持 | |
| 52.03K | $378.26K | 0.00% | 增持 | |
| 45.25K | $328.96K | 0.00% | 增持 | |
| 33.28K | $241.96K | 0.00% | 减持 | |
| 32.73K | $237.97K | 0.00% | 持有 | |
| 31.27K | $227.34K | 0.00% | 增持 | |
| 29.55K | $214.71K | 0.00% | 增持 | |
| 25.05K | $182.08K | 0.00% | 减持 | |
| 10.51K | $76.39K | 0.00% | 减持 | |
| 5.83K | $40.74K | 0.00% | 持有 | |
| 2.47K | $17.96K | 0.00% | 增持 |
Q4 2022 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.39M | $32.02M | 0.00% | 增持 | |
| 3.25M | $23.70M | 0.01% | 减持 | |
| 3.20M | $23.31M | 0.12% | 减持 | |
| 1.47M | $10.72M | 0.00% | 增持 | |
| 724.31K | $5.28M | 0.00% | 增持 | |
| 415.78K | $3.03M | 0.00% | 增持 | |
| 255.73K | $1.86M | 0.00% | 增持 | |
| 241.65K | $1.76M | 0.00% | 增持 | |
| 220.50K | $1.61M | 0.00% | 增持 | |
| 131.28K | $957.00K | 0.00% | 减持 | |
| 125.25K | $914.00K | 0.00% | 增持 | |
| 100.76K | $734.52K | 0.00% | 增持 | |
| 45.67K | $332.93K | 0.00% | 增持 | |
| 43.82K | $319.43K | 0.00% | 增持 | |
| 32.73K | $238.62K | 0.00% | 增持 | |
| 32.61K | $237.74K | 0.00% | 减持 | |
| 29.94K | $218.24K | 0.00% | 增持 | |
| 26.71K | $194.70K | 0.00% | 增持 | |
| 24.60K | $179.33K | 0.00% | 新进 | |
| 23.70K | $173.00K | 0.00% | 减持 | |
| 13.94K | $101.54K | 0.00% | 新进 | |
| 10.62K | $77.38K | 0.00% | 新进 | |
| 7.00K | $51.03K | 0.00% | 减持 | |
| 5.83K | $42.32K | 0.00% | 新进 | |
| 942 | $6.87K | 0.00% | 减持 |
Q3 2022 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.88M | $29.96M | 0.00% | 增持 | |
| 3.69M | $28.54M | 0.17% | 增持 | |
| 3.68M | $28.45M | 0.01% | 增持 | |
| 1.32M | $10.22M | 0.03% | 新进 | |
| 1.26M | $9.76M | 0.00% | 减持 | |
| 642.81K | $4.97M | 0.00% | 持有 | |
| 360.86K | $2.79M | 0.00% | 新进 | |
| 225.65K | $1.74M | 0.00% | 增持 | |
| 192.23K | $1.49M | 0.00% | 持有 | |
| 182.45K | $1.41M | 0.00% | 减持 | |
| 180.36K | $1.39M | 0.00% | 增持 | |
| 178.69K | $1.38M | 0.00% | 减持 | |
| 139.88K | $1.08M | 0.00% | 增持 | |
| 115.10K | $890.00K | 0.00% | 新进 | |
| 49.98K | $387.00K | 0.00% | 新进 | |
| 40.81K | $315.00K | 0.00% | 增持 | |
| 39.70K | $307.00K | 0.00% | 新进 | |
| 31.94K | $246.00K | 0.00% | 减持 | |
| 29.47K | $228.00K | 0.00% | 减持 | |
| 28.52K | $221.00K | 0.00% | 增持 | |
| 26.05K | $201.00K | 0.00% | 增持 | |
| 19.92K | $155.00K | 0.00% | 减持 | |
| 10.60K | $82.00K | 0.00% | 减持 | |
| 9.16K | $70.00K | 0.00% | 减持 | |
| 1.49K | $12.00K | 0.00% | 减持 |
新建仓(最新)
本季度没有基金新建该仓位。
完全清仓(较上季)
本季度没有被追踪基金完全清仓。
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| LMR Partners LLP | 518.70K | — | — | — | — | — | — | — | — | — |
| Blue Trust, Inc. | 127 | — | — | — | — | — | — | — | — | — |
| BVF INC/IL | — | 10.56M | — | — | — | — | — | — | — | — |
| Vanguard Group | — | 4.67M | 4.46M | 4.43M | 4.39M | 3.88M | 3.45M | 3.20M | 1.43M | 1.46M |
| Point72 Asset Management | — | 789.10K | 1.93M | 3.11M | 3.20M | 3.69M | 1.95M | 42.27K | — | — |
| STATE STREET CORP | — | 3.53M | — | — | — | — | — | — | — | — |
| GREAT POINT PARTNERS LLC | — | 2.91M | — | — | — | — | — | — | — | — |
| Deep Track Capital, LP | — | 2.78M | — | — | — | — | — | — | — | — |
| Bellevue Group AG | — | 2.35M | — | — | — | — | — | — | — | — |
| Geode Capital Management | — | 1.90M | 1.73M | 1.58M | 1.47M | 1.26M | 1.33M | 699.68K | 620.88K | 511.62K |
| PFM Health Sciences, LP | — | 1.61M | — | — | — | — | — | — | — | — |
| THRIVENT FINANCIAL FOR LUTHERANS | — | 1.11M | — | — | — | — | — | — | — | — |
| Northern Trust Corp | — | 822.03K | 801.19K | 756.26K | 724.31K | 642.81K | 644.82K | 136.88K | 139.32K | 129.88K |
| JOHNSON & JOHNSON | — | 1.00M | — | — | — | — | — | — | — | — |
| SPHERA FUNDS MANAGEMENT LTD. | — | 952.64K | — | — | — | — | — | — | — | — |
| AMERICAN CENTURY COMPANIES INC | — | 794.61K | — | — | — | — | — | — | — | — |
| Onex Canada Asset Management Inc. | — | 772.90K | — | — | — | — | — | — | — | — |
| Pier Capital, LLC | — | 732.94K | — | — | — | — | — | — | — | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | — | 689.18K | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | — | 607.05K | 649.99K | 1.74K | 125.25K | 40.81K | 39.78K | 20.16K | 36.39K | — |
常见问题
Which funds hold PNT?
132 funds have reported positions in PNT across five years of 13F filings; the sum of their latest reported stakes is $364.08M.
Who are the top institutional holders of PNT?
The largest 13F holders are BVF INC/IL, Vanguard Group, STATE STREET CORP, GREAT POINT PARTNERS LLC, Deep Track Capital, LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of POINT BIOPHARMA GLOBAL INC?
The major shareholders of POINT BIOPHARMA GLOBAL INC (PNT) by reported 13F value are BVF INC/IL, Vanguard Group, STATE STREET CORP, GREAT POINT PARTNERS LLC, Deep Track Capital, LP, among 132 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.